Asterios Deligiannis | Medicine | Best Innovation Award

Published on by Scientific World Research Awards

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en

Jack Ng Kok Wah | Public Health | Best Health Science Research Award

Published on by Scientific World Research Awards

Dr. Jack Ng Kok Wah | Public Health | Best Health Science Research Award

Senior Lecturer | Multimedia University | Malaysia

 

Dr. Jack Ng Kok Wah’s research lies at the intersection of artificial intelligence (AI), surgical innovation, and biomedical engineering, with a strong emphasis on developing AI-driven robotic systems that enhance precision, reduce surgical risks, and revolutionize patient outcomes. His body of work demonstrates a deep commitment to integrating machine learning algorithms and intelligent automation into modern surgical practices, thereby addressing one of the most critical needs in healthcare—precision and safety in complex procedures.A significant aspect of his research explores how robotic technologies and AI-assisted decision systems can transform traditional surgical approaches. By leveraging real-time data analytics, sensor fusion, and computer vision, Dr. Wah contributes to the design of systems that support surgeons in performing minimally invasive procedures with unprecedented accuracy. His work not only advances the technical frontiers of robotic surgery but also examines the broader ethical, clinical, and operational implications of implementing such technologies in real-world healthcare environments.Beyond surgical robotics, Dr. Wah’s research interests extend to digital health innovation, medical imaging, and intelligent clinical systems. He investigates how data-driven approaches can improve diagnostic accuracy, predict patient outcomes, and personalize treatment protocols. Through his publications, he emphasizes the transformative potential of AI to bridge gaps between human expertise and machine efficiency, promoting a synergistic model of healthcare delivery that enhances both safety and accessibility.With a growing citation record and interdisciplinary collaborations, Dr. Wah continues to contribute to the advancement of next-generation medical technologies that merge computing power with human insight. His vision encapsulates a future where AI and robotics are not merely tools but trusted partners in surgical and clinical decision-making, ultimately redefining standards of care in the medical field. His scholarly contributions reinforce his standing as a forward-thinking researcher committed to shaping the future of intelligent healthcare systems and precision surgery.

Profiles: Scopus | ORCID | Google Scholar | ResearchGate 

Featured Publications

  1. Wah, J. N. K. (2025). Revolutionizing surgery: AI and robotics for precision, risk reduction, and innovation. Journal of Robotic Surgery, 19(Article No. 47).
    Citations: 39

  2. Wah, J. N. K. (2025). Revolutionizing e-Health: The transformative role of AI-powered hybrid chatbots in healthcare solutions. Frontiers in Public Health, 13.
    Citations: 29

  3. Wah, J. N. K. (2025). The rise of robotics and AI-assisted surgery in modern healthcare. Journal of Robotic Surgery, 19(1), 311.
    Citations: 13

  4. Ng, J., Wah, K., Fitriana, M., & Arumugam, T. (2023). Assumptions for structural equation modeling (SEM), normality of data distribution analysis & model fit measures. In Normality of Data Distribution Analysis & Model Fit Measures.
    Citations: 12

  5. Wah, K., & Ng, J. (2025). AI-driven robotic surgery in oncology: Advancing precision, personalization, and patient outcomes. Journal of Robotic Surgery, 19(1), 1–11.
    Citations: 7

Dr. Jack Ng Kok Wah envisions a future where artificial intelligence and robotic systems seamlessly integrate into healthcare, enabling safer, smarter, and more precise surgical interventions. His pioneering research drives innovations that enhance patient outcomes, optimize clinical workflows, and redefine the frontiers of intelligent medicine.

Nasser Mousa | Public Health | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Nasser Mousa | Public Health | Best Paper Award

Professor | Mansoura University | Egypt

Prof. Dr. Nasser Hamed Mousa is a renowned Egyptian medical scientist and hepatologist, serving at the Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. With a Scopus record of 1,028 citations, 47 scientific publications, and an h-index of 16, he has made exceptional contributions to the fields of hepatology, gastroenterology, metabolic diseases, and translational medicine. Prof. Mousa earned his M.B.B.Ch., M.Sc., and Ph.D. in Hepatology and Gastroenterology from leading Egyptian medical universities, where he developed a strong foundation in internal medicine and liver pathology. Over the years, he has built an impressive professional career focusing on clinical hepatology, particularly viral hepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). His research interests encompass liver disease surveillance, nanomedicine, cancer biology, and metabolic dysfunction-associated steatotic liver disease (MASLD). Notably, his recent studies on individualized HCC risk stratification and gold nanoparticle-mediated cancer therapy have gained international recognition for their innovative clinical and molecular insights. Prof. Mousa’s research skills span molecular diagnostics, clinical trial design, bioinformatics-based network pharmacology, and predictive modeling for liver disease outcomes, reflecting his multidisciplinary expertise. His collaboration with national and international research teams underscores his leadership in evidence-based hepatology. Prof. Mousa has also contributed to advancing precision medicine approaches for patients with chronic liver disease, integrating laboratory science with clinical decision-making. Throughout his career, he has received numerous academic honors and institutional recognitions for his excellence in research, publication impact, and contribution to medical innovation. In conclusion, Prof. Dr. Nasser Hamed Mousa stands as a distinguished figure in liver research, embodying excellence in scientific inquiry, clinical innovation, and academic leadership, while his impactful body of work continues to influence global hepatology and improve patient outcomes in Egypt and worldwide.

Profiles: Scopus | ORCID 

Featured Publications

  1. Mousa, N., Elbaz, S., Elmetwalli, A., Mansour, M., Abdelsalam, M., Abdelaziz, M., Hashem, M., El-Emam, O., El-wakeel, N., Elgamal, A., et al. (2025). A risk stratification score for predicting first episode of upper gastrointestinal bleeding in patients with cirrhosis. Archives of Medical Research.

  2. Mousa, N., Elmetwalli, A., Abdel-Razik, A., Mousa, E., Abdelsalam, M., Elbaz, S., El-wakeel, N., Eldars, W., Gad, E., Arafa, M., et al. (2025, September 15). Periodontitis and metabolic dysfunction-associated steatotic liver disease: Emphasizing the clinical interplay between hepatologists and dentists. Odontology.

  3. Mousa, N., Elbaz, S., Elmetwalli, A., Abdelsalam, M., Abdelkader, E., Wahba, M., Abdelaziz, M., El-Emam, O., El-wakeel, N., Shaheen, M., et al. (2025, April 16). Neutrophil percentage-to-albumin ratio as a predictor of acute kidney injury in cirrhotic patients: A novel approach utilizing artificial intelligence. American Journal of Nephrology.

  4. Shiha, G., Mousa, N., Soliman, R., Mikhail, N. N. H., Elbasiony, M. A., & Khattab, M. (2020, July). Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study. Journal of Viral Hepatitis.

  5. Elbaz, S., Mousa, N., Besheer, T., Sheta, T., Taha, K., Awad, M., Effat, N., Elgamal, A., & Abdel-Razik, A. (2020, April 2). Malondialdehyde and C-reactive protein as prognostic markers of hepatocellular carcinoma. British Journal of Biomedical Science.

 

Yigit Akin | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Yigit Akin | Medicine | Best Researcher Award

Yigit Akin | Izmir Kâtip Celebi University School of Medicine | Turkey

Professor Yigit Akin is a distinguished urologist and academic leader specializing in uro-oncology, robotic surgery, and minimally invasive laparoscopy. He earned his M.D. from Ege University Faculty of Medicine in 2004 and completed advanced training in robotics, laparoscopy, and uro-oncology at Klinikum Heilbronn, Germany, between 2013 and 2014. Currently, he serves as Head of Urology at Izmir Katip Celebi University, Turkey, leading one of the country’s premier uro-oncology centers. With over 210 peer-reviewed publications, 14 book chapters, and editorial board memberships in international journals, his contributions are well recognized in PubMed and IEEE-indexed forums. He has directed multiple multidisciplinary and international research projects, notably pioneering the extraperitoneal laparoscopic radical prostatectomy using 3 trocars (#3trocarsELRP), with more than 1300 successful procedures. A global mentor in laparoscopic surgery, Prof. Akin has conducted live surgical workshops and training in over 10 countries, while also supervising international clinical fellows. His leadership extends to community-based medical training, editorial contributions, and professional memberships in leading medical and surgical associations. Prof. Akin is strongly positioned to lead next-generation cancer genetics and surgical innovation research. His expertise in developing novel laparoscopic techniques, combined with mentorship of global fellows, demonstrates the potential to advance robotic uro-oncology surgery, elevate Q1 journal contributions, and strengthen international collaborations that will shape the future of minimally invasive urology worldwide.

Profile: ORCID 

Featured Publications

orulmaz, E. M., Dönmez, K., Görgel, S. N., & Akin, Y. (2025). Penil fraktür nedeniyle opere edilen hastaların klinik sonuçları ve komplikasyonlarla ilişkili faktörler: 10 yıllık sonuçlarımız. Androloji Bülteni.

Tekinaslan, H., Görgel, S. N., & Akin, Y. (2025). Malekot kateter kırığına bağlı retroperitoneal yabancı cisim: Nadir bir olgu sunumu. Endouroloji Bülteni.

Dama, M., Yorulmaz, E. M., Özcan, S., Köse, O., Görgel, S. N., & Akin, Y. (2025). AISI, SIRI, and MLR in predicting surgical outcomes after radical cystectomy: Revisiting inflammatory risk markers. Medicina, 61(10), 1756.

Dama, M., Yorulmaz, E. M., Özcan, S., Köse, O., Görgel, S. N., & Akin, Y. (2025). Optimising imaging strategies in suspected urolithiasis: Effects on diagnostic and therapeutic timelines. Harran Üniversitesi Tıp Fakültesi Dergisi.

Özcan, S., Dama, M., Yorulmaz, E. M., Köse, O., Görgel, S. N., & Akin, Y. (2025). Holmium laser enucleation of the prostate and postoperative dysuria: A 20-year bibliometric perspective. Trends in Surgical Sciences.